DICE Therapeutics Inc.

47.55
0.03 (0.06%)
At close: Aug 08, 2023, 8:00 PM

DICE Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021 Q4 2020 Q3 2020
Period Ending Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020
n/a n/a n/a n/a n/a n/a n/a n/a 1.13M n/a 188K 225K
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
n/a n/a n/a n/a n/a n/a n/a n/a 1.13M n/a 188K 225K
-39.5M -31.57M -26.45M -21.17M -21.74M -18.86M -16.21M -16.13M -7.17M -8.09M -7.06M -5.98M
4.68M 5.93M 3.7M 702K 487K 327K 75K 20K 27K 14K -13K 7K
-34.82M -25.65M -23.22M -20.55M -21.52M -18.59M -16.2M -17.34M -7.36M -8.07M -7.13M -6.02M
-34.82M -19.72M -22.61M -19.93M -21.72M -18.59M -16.2M -17.34M -7.36M -8.07M -7.13M -6.02M
11.3M 7.91M 6.36M 6.44M 7.41M 5.45M 4M 4.44M 2.32M 1.47M 1.19M 1.75M
28.2M 23.66M 20.09M 14.73M 14.33M 13.41M 12.21M 11.69M 5.98M 6.62M 6.06M 4.46M
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
39.5M 31.57M 26.45M 21.17M 21.74M 18.86M 16.21M 16.13M 8.3M 8.09M 7.25M 6.21M
n/a n/a 471K 83K 65K 60K 60K 60K 52K 2K 2K 3K
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
39.5M 31.57M 26.45M 21.17M 21.74M 18.86M 16.21M 16.13M 8.3M 8.09M 7.25M 6.21M
4.68M -5.93M -609K -619K 200K 327K -81K 60K 52K 2K 2K 3K
47.31M 47.19M 45.43M 37.48M 37.36M 37.26M 37.16M 7.55M 34.32M 23.23M n/a 23.23M
47.31M 47.19M 45.43M 37.48M 37.36M 37.26M 37.16M 7.55M 34.32M 23.23M n/a 23.23M
-0.74 -0.42 -0.5 -0.53 -0.58 -0.5 -0.44 -2.3 -0.21 -0.35 n/a -0.26
-0.74 -0.42 -0.5 -0.53 -0.58 -0.5 -0.44 -2.3 -0.21 -0.35 n/a -0.26
-34.13M -25.65M -22.75M -19.87M -20.56M -18.01M -16.14M -15.97M -6.97M -7.89M -6.9M -5.81M
n/a n/a -22.75M -20.47M -21.46M -18.53M -16.14M -17.27M -7.29M -8.08M -7.11M -6.02M
687K 5.93M 3.7M 1.3M 1.19M 519K 156K 146K 179K 180K 172K 169K